Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

RGEN – Repligen Corporation

Repligen Corporation
RGEN
$123.56
Name : Repligen Corporation
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $6,941,983,744.00
EPSttm : -0.42
finviz dynamic chart for RGEN
Repligen Corporation
$123.56
0.52%
$0.65

Float Short %

6.38

Margin Of Safety %

-13

Put/Call OI Ratio

4.38

EPS Next Q Diff

0.01

EPS Last/This Y

2.14

EPS This/Next Y

0.48

Price

123.57

Target Price

182.12

Analyst Recom

1.57

Performance Q

-9.89

Relative Volume

0.95

Beta

1.12

Ticker: RGEN




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02RGEN118.544.920.019825
2025-06-03RGEN124.424.712.709898
2025-06-04RGEN126.594.605.089947
2025-06-05RGEN126.754.62141.3010014
2025-06-06RGEN128.34.050.208981
2025-06-09RGEN131.694.070.288975
2025-06-10RGEN132.894.040.038990
2025-06-11RGEN131.363.671.579175
2025-06-12RGEN131.33.671.009187
2025-06-13RGEN127.533.660.339190
2025-06-16RGEN126.233.660.049189
2025-06-17RGEN120.883.551.009224
2025-06-18RGEN117.473.540.299202
2025-06-20RGEN118.683.3538.188944
2025-06-23RGEN120.054.690.328681
2025-06-24RGEN123.224.650.638696
2025-06-25RGEN124.054.630.098703
2025-06-26RGEN124.134.500.118748
2025-06-27RGEN123.554.380.008798
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02RGEN118.6417.266.61.68
2025-06-03RGEN124.4017.269.41.68
2025-06-04RGEN126.5517.267.41.68
2025-06-05RGEN126.7018.866.31.68
2025-06-06RGEN128.4118.867.11.68
2025-06-09RGEN131.6818.868.01.68
2025-06-10RGEN132.8519.366.91.68
2025-06-11RGEN132.0519.365.91.68
2025-06-12RGEN131.3019.365.91.68
2025-06-13RGEN127.4819.364.41.68
2025-06-16RGEN126.1319.365.61.68
2025-06-17RGEN121.0219.363.71.68
2025-06-18RGEN117.5419.364.41.68
2025-06-20RGEN118.8519.367.01.68
2025-06-23RGEN120.1019.367.01.68
2025-06-24RGEN123.3819.368.01.68
2025-06-25RGEN124.0819.366.71.68
2025-06-26RGEN124.1919.366.30.00
2025-06-27RGEN123.5719.365.91.68
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02RGEN-1.702.016.40
2025-06-03RGEN-1.702.016.40
2025-06-04RGEN-1.702.016.40
2025-06-05RGEN-1.702.016.40
2025-06-06RGEN-1.702.016.40
2025-06-09RGEN-1.702.036.40
2025-06-10RGEN-1.702.036.40
2025-06-11RGEN-1.702.036.49
2025-06-12RGEN-1.702.036.49
2025-06-13RGEN-1.702.036.49
2025-06-16RGEN-1.702.346.49
2025-06-18RGEN-1.702.346.49
2025-06-20RGEN-1.702.346.49
2025-06-23RGEN-1.702.066.49
2025-06-24RGEN-1.702.066.49
2025-06-25RGEN-1.702.066.49
2025-06-26RGEN-1.702.066.38
2025-06-27RGEN-1.702.066.38
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

0.39

Avg. EPS Est. Current Quarter

0.39

Avg. EPS Est. Next Quarter

0.4

Insider Transactions

-1.7

Institutional Transactions

2.06

Beta

1.12

Average Sales Estimate Current Quarter

174

Average Sales Estimate Next Quarter

175

Fair Value

107.89

Quality Score

55

Growth Score

71

Sentiment Score

90

Actual DrawDown %

62.3

Max Drawdown 5-Year %

-66.4

Target Price

182.12

P/E

Forward P/E

56.76

PEG

P/S

10.67

P/B

3.5

P/Free Cash Flow

57.98

EPS

-0.41

Average EPS Est. Cur. Y​

1.68

EPS Next Y. (Est.)

2.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.53

Relative Volume

0.95

Return on Equity vs Sector %

-25.1

Return on Equity vs Industry %

-9.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

65.9
Repligen Corporation
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 1778
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
stock quote shares RGEN – Repligen Corporation Stock Price stock today
news today RGEN – Repligen Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch RGEN – Repligen Corporation yahoo finance google finance
stock history RGEN – Repligen Corporation invest stock market
stock prices RGEN premarket after hours
ticker RGEN fair value insiders trading